100 related articles for article (PubMed ID: 32669314)
1. Antiproliferative Effects of Monoclonal Antibodies against (Pro)Renin Receptor in Pancreatic Ductal Adenocarcinoma.
Rahman A; Matsuyama M; Ebihara A; Shibayama Y; Hasan AU; Nakagami H; Suzuki F; Sun J; Kobayashi T; Hayashi H; Nakano D; Kobara H; Masaki T; Nishiyama A
Mol Cancer Ther; 2020 Sep; 19(9):1844-1855. PubMed ID: 32669314
[TBL] [Abstract][Full Text] [Related]
2. (Pro)renin receptor is crucial for Wnt/β-catenin-dependent genesis of pancreatic ductal adenocarcinoma.
Shibayama Y; Fujimori T; Nguyen G; Hirose T; Totsune K; Ichihara A; Kitada K; Nakano D; Kobori H; Kohno M; Masaki T; Suzuki Y; Yachida S; Nishiyama A
Sci Rep; 2015 Mar; 5():8854. PubMed ID: 25747895
[TBL] [Abstract][Full Text] [Related]
3. (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.
Wang J; Shibayama Y; Zhang A; Ohsaki H; Asano E; Suzuki Y; Kushida Y; Kobara H; Masaki T; Wang Z; Nishiyama A
Br J Cancer; 2019 Jan; 120(2):229-237. PubMed ID: 30555158
[TBL] [Abstract][Full Text] [Related]
4. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.
Arensman MD; Telesca D; Lay AR; Kershaw KM; Wu N; Donahue TR; Dawson DW
Mol Cancer Ther; 2014 Oct; 13(10):2303-14. PubMed ID: 25082960
[TBL] [Abstract][Full Text] [Related]
5. DHA-SBT-1214 Taxoid Nanoemulsion and Anti-PD-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model.
Ahmad G; Mackenzie GG; Egan J; Amiji MM
Mol Cancer Ther; 2019 Nov; 18(11):1961-1972. PubMed ID: 31439714
[TBL] [Abstract][Full Text] [Related]
6. Mapping the protein binding site of the (pro)renin receptor using in silico 3D structural analysis.
Ebihara A; Sugihara D; Matsuyama M; Suzuki-Nakagawa C; Nabi AHMN; Nakagawa T; Nishiyama A; Suzuki F
Hypertens Res; 2023 Apr; 46(4):959-971. PubMed ID: 36481966
[TBL] [Abstract][Full Text] [Related]
7. Sauchinone inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma cells through the Wnt/β-catenin pathway.
Qiao Y; Yan LJ; Yan C
Anticancer Drugs; 2020 Oct; 31(9):918-924. PubMed ID: 32889895
[TBL] [Abstract][Full Text] [Related]
8. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
[TBL] [Abstract][Full Text] [Related]
9. WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma.
Arensman MD; Kovochich AN; Kulikauskas RM; Lay AR; Yang PT; Li X; Donahue T; Major MB; Moon RT; Chien AJ; Dawson DW
Oncogene; 2014 Feb; 33(7):899-908. PubMed ID: 23416978
[TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
11. Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux.
Carozzo A; Yaneff A; Gómez N; Di Siervi N; Sahores A; Diez F; Attorresi AI; Rodríguez-González Á; Monczor F; Fernández N; Abba M; Shayo C; Davio C
Mol Pharmacol; 2019 Jul; 96(1):13-25. PubMed ID: 31043460
[TBL] [Abstract][Full Text] [Related]
12. Aberrant (pro)renin receptor expression induces genomic instability in pancreatic ductal adenocarcinoma through upregulation of SMARCA5/SNF2H.
Shibayama Y; Takahashi K; Yamaguchi H; Yasuda J; Yamazaki D; Rahman A; Fujimori T; Fujisawa Y; Takai S; Furukawa T; Nakagawa T; Ohsaki H; Kobara H; Wong JH; Masaki T; Yuzawa Y; Kiyomoto H; Yachida S; Fujimoto A; Nishiyama A
Commun Biol; 2020 Nov; 3(1):724. PubMed ID: 33247206
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
14. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
15. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
[TBL] [Abstract][Full Text] [Related]
16. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract][Full Text] [Related]
17. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
18. Combined evaluation of proliferation and apoptosis to calculate IC
Ekici Y; Yilmaz A; Kucuksezer UC; Gazioglu SB; Yamalioglu ZD; Gurol AO; Linn T; Tuncer FN
Med Oncol; 2021 Aug; 38(9):109. PubMed ID: 34357487
[TBL] [Abstract][Full Text] [Related]
19. Effects of a monoclonal antibody against (pro)renin receptor on gliomagenesis.
Fujimori T; Shibayama Y; Kanda T; Suzuki K; Ogawa D; Ishikawa R; Kadota K; Matsunaga T; Tamiya T; Nishiyama A; Miyake K
Sci Rep; 2023 Jan; 13(1):808. PubMed ID: 36646875
[TBL] [Abstract][Full Text] [Related]
20. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
